PAYS D'ORIGINE NOM DOSAGE FORME NR ST LABORATOIRE ALPHAPRESS 1 1 MG 20 TABLETS 23900/07 AMLORINE 10 10MG 30 TABLETS /10 REMEDICA LTD CHYPRE
|
|
|
- Beverly Rachel Reynolds
- 6 years ago
- Views:
Transcription
1 NOM DOSAGE FORME NR ST LABORATOIRE PAYS D'ORIGINE ALPHAPRESS 1 1 MG 20 TABLETS 23900/07 MIDDLE EAST PHARMACEUTICAL CO- MIDPHARMA JORDANIE AMLORINE 10 10MG 30 TABLETS /10 REMEDICA LTD CHYPRE AMLORINE 5 5MG 30 TABLETS /10 REMEDICA LTD CHYPRE ANTALIP MG 30 FILM COATED TABLETS 24671/07 REMEDICA LTD CHYPRE Page 1
2 BI PROFENID L.P. 100MG 20 COMPRIMES SECABLES A LIBERATION PROLONGEE /11 FAMAR LYON FOR SANOFI AVENTIS-FRANCE FRANCE BINOCRIT 2000 IU/1ML 1 ML X 6 PRE-FILLED SYRINGES FOR SC. AND IV. USE /11 * SANDOZ GMBH AUTRICHE BINOCRIT 4000 IU/0.4ML 0.4 ML X 6 PRE-FILLED SYRINGES FOR SC. AND IV. USE /11 * SANDOZ GMBH AUTRICHE BINOCRIT IU/1ML 1 ML X 6 PRE-FILLED SYRINGES FOR SC. AND IV. USE /11 * SANDOZ GMBH AUTRICHE BUTOSOL 10ML AEROSOL INHALER /10 LABORATORIO ALDO- UNION S.A-SPAIN ESPAGNE CARBOPLATIN VIANEX 150MG/15ML 15ML X 1 VIAL OF /10 * VIANEX S.A.-PLANT C GRECE CARBOPLATINE MYLAN 10MG/ML 15ML X 1VIAL OF SOLUTION FOR I.V. INFUSION /09 * BENTA S.A.L UNDER LICENSE FROM MYLAN S.A.S-FRANCE CEFPROZ 250MG/5ML 50ML POWDER FOR ORAL SUSPENSION /09 MEDPHARMA PHARMA & CHEM IND S LLC EMIRATS ARABES UNIS Page 2
3 CEFZIL 500MG 10 FILM COATED TABLETS /10 CEFZIL 250MG 10 FILM COATED TABLETS /10 PACKED BY PHARMALINE UNDER LICENSE OF GLAXOSMITHKLINE EXPORT LIMITED-UK PACKED BY PHARMALINE UNDER LICENSE OF GLAXOSMITHKLINE EXPORT LIMITED-UK CITAPRAM-PIC 20MG 30 TABLETS 24539/07 PHARMA INTERNATIONAL CO. JORDANIE CITAPRAM-PIC 40MG 30 TABLETS 24540/07 PHARMA INTERNATIONAL CO. JORDANIE CLAREM MG 14 FILM COATED TABLETS 24657/07 REMEDICA LTD CHYPRE CLINDAMYCIN VIANEX 600MG/4ML 4ML X 1 AMPOULE OF SOLUTION FOR INJECTION /10 VIANEX S.A.-PLANT A GRECE CONVULEX 100MG/ML 5ML X 5 AMPOULES OF SOLUTION FOR INJECTION OR INFUSION /09 G.L PHARMA GMBH FOR GEROT PHARMAZEUTIKA GMBH- AUSTRIA AUTRICHE DAXAS 500MCG 30 FILM COATED TABLETS /11 NYCOMED GMBH ALLEMAGNE Page 3
4 DECAPEPTYL L.P. 22.5MG 1 VIAL POWDER FOR SUSPENSION FOR I.M INJECTION+2 ML SOLVENT /11 * IPSEN PHARMA BIOTECH FOR IPSEN PHARMA-FRANCE FRANCE DELINE 5MG 10 TABLETS /11 MEDIPHAR LABORATORIES DOCETAXEL HOSPIRA 20MG/2ML 2ML X 1VIAL OF CONCENTRATE FOR /11 * HOSPIRA UK LIMITED UK DOCETAXEL HOSPIRA 80MG/8ML 8ML X 1VIAL OF CONCENTRATE FOR /11 * HOSPIRA UK LIMITED UK DOCETAXEL HOSPIRA 160MG/16ML 16ML X 1VIAL OF CONCENTRATE FOR /11 * HOSPIRA UK LIMITED UK DURICEF 500MG 16 CAPSULES /10 PACKED BY PHARMALINE UNDER LICENSE OF GLAXOSMITHKLINE EXPORT LIMITED-UK EPOTEX 2000 BENTA 2000IU 1 PRE-FILLED SYRINGE /08 * BENTA S.A.L Page 4
5 EPOTEX 4000 BENTA 4000IU 1 PRE-FILLED SYRINGE /08 * BENTA S.A.L EXONAR 40MG 14 DELAYED RELEASE CAPSULES /10 ALGORITHM S.A.L FONGAMIL 1% 30G SOLUTION POUR APPLICATION LOCALE EN FLACON PRESSURISE /10 LABORATOIRES CHEMINEAU POUR LABORATOIRE BAILLEUL- BIORGA-FRANCE FRANCE FONGAMIL 1% 15G CREAM /10 LABORATOIRES CHEMINEAU POUR LABORATOIRE BAILLEUL- BIORGA-FRANCE FRANCE GASTROPAN 40MG 15 ENTERIC COATED TABLETS 24520/07 TABUK PHARMACEUTICAL MFG.CO ARABIE SEOUDITE GASTROPAN 40MG 30 ENTERIC COATED TABLETS 24519/07 TABUK PHARMACEUTICAL MFG.CO ARABIE SEOUDITE GEMCITABIN EBEWE 2000MG/50ML 50ML X 1VIAL OF CONCENTRATE FOR /11 * EBEWE PHARMA GES.M.B.H.NFG.KG AUTRICHE GEMCITABINE 2G 2G 1VIAL POWDER FOR /11 * HOSPIRA UK LIMITED UK Page 5
6 HIKMA CEFAZOLIN 1000MG 1 VIAL /11 HIKMA FARMACEUTICA FOR HIKMA PHARMACEUTICALS- JORDAN PORTUGAL INUVER (100 MCG+6 MCG)/DOSE 120 ACTUATIONS OF PRESSURISED INHALATION SOLUTION /10 CHIESI FARMACEUTICI S.P.A ITALIE IRINOTECAN THYMOORGAN 40MG/2ML 1 VIAL OF STERILE CONCENTRATE FOR /10 * THYMOORGAN PHARMAZIE GMBH FOR HIKMA PHARMACEUTICALS-JORDAN ALLEMAGNE IRINOTECAN THYMOORGAN 100MG/5ML 1 VIAL OF STERILE CONCENTRATE FOR /10 * THYMOORGAN PHARMAZIE GMBH FOR HIKMA PHARMACEUTICALS-JORDAN ALLEMAGNE JOSWE GLEMAX 6 6MG 30 CAPLETS /10 JOSWE MEDICAL( JORDAN SWEDEN MEDICAL AND STERILIZATION CO.) JORDANIE KINODROX 600MG 5 FILM COATED TABLETS 96372/11 ALGORITHM S.A.L UNDER LICENSE FROM NIPPON SHINYAKU CO. LTD,KYOTO- JAPAN LECITAL 20 20MG 30 CAPLETS 24896/07 JOSWE MEDICAL( JORDAN SWEDEN MEDICAL AND STERILIZATION CO.) JORDANIE Page 6
7 LENDOMAX 70MG 4 TABLETS /08 * TABUK PHARMACEUTICAL MFG.CO ARABIE SEOUDITE LEUPRO-SANDOZ 3.6MG 1 MONTH DEPOT IMPLANT X 1 PRE-FILLED SYRINGE FOR SUBCUTANEOUS INJECTION /11 * LIPITOR 80MG 30 FILM COATED TABLETS /11 MEDACIN T 1% 30G TOPICAL GEL /10 JENAHEXAL PHARMA GMBH FOR SANDOZ PHARMACEUTICALS GMBH- GERMANY PFIZER MANUFACTURING DEUTSCHLAND GMBH UNDER LICENCE OF PARKE-DAVIS GMBH MEDPHARMA PHARMA & CHEM IND S LLC ALLEMAGNE ALLEMAGNE EMIRATS ARABES UNIS MELIXITE 0.5MG+10MG 10 STRIPS X 10 FILM COATED TABLETS /10 HELIOS PHARMACEUTICALS INDE MOLCET 325MG+37.5MG 10 TABLETS /10 PACKED BY PHARMADEX S.A.L UNDER LICENSE FROM ORBUCELL PHARMA-CANADA NADIXA 1% 25G CREAM /08 FERRER INTERNACIONAL S.A. ESPAGNE NAFTILUX 200MG 20 GELULES /09 THERABEL INDUSTRIES FOR THERABEL LUCIEN PHARMA- FRANCE FRANCE Page 7
8 NALOXONE HIKMA 0.4MG/ML 1ML X 6 AMPOULES /10 HIKMA FARMACEUTICA FOR HIKMA PHARMACEUTICALS- JORDAN PORTUGAL NATECAL D3 600 MG+400 UI 60 ORODISPERSIBLE TABLETS /11 ITALFARMACO S.P.A ITALIE ONBREZ BREEZHALER 300 MCG 30 HARD CAPSULES OF INHALATION POWDER +BREEZHALER 96368/11 NOVARTIS PHARMA STEIN AG FOR NOVARTIS PHARMA AG- SWITZERLAND SUISSE ONDANSETRON AGUETTANT 4MG/2ML 2ML X 10 AMPOULES OF SOLUTION FOR I.V USE /08 LABORATOIRE AGUETTANT FRANCE ORAVIL 100,000IU/2ML 1VIAL OF ORAL SOLUTION /11 LABORATORIO BROBEL SRL FOR LABORATORIOS TRB PHARMA S.A.-ARGENTINE ARGENTINE OTRIVIN 0.05% 10ML METERED DOSE NASAL SPRAY 96403/11 NOVARTIS CONSUMER HEALTH SA SUISSE OXALIPLATINE MYLAN 50MG/10ML 50MG POWDER FOR /09 * BENTA S.A.L UNDER LICENSE FROM MYLAN S.A.S-FRANCE Page 8
9 OXALIPLATINE MYLAN 100MG/20ML 100MG POWDER FOR /09 * BENTA S.A.L UNDER LICENSE FROM MYLAN S.A.S-FRANCE PANTHRON 40MG 30 ENTERIC COATED TABLETS /11 PHARMAPACK TECHNOLOGIES PTY LTD FOR ERIS PHARMACEUTICALS AUSTRALIA PTY LTD AUSTRALIE PEITEL 0.25% 30G CREAM FOR TOPICAL USE /09 FERRER INTERNACIONAL S.A FOR LABORATORIOS NOVAG S.A-SPAIN ESPAGNE PLAVIX 75MG 75MG 28 FILM COATED TABLETS /10 * PACKED BY BENTA S.A.L. UNDER LICENSE FROM SANOFI PHARMA BRISTOL MYERS SQUIBB SNC-FRANCE PROFEMIGR 150MG 10 COMPRIMES SECABLES /11 FAMAR LYON FOR SANOFI AVENTIS-FRANCE FRANCE RAZVAN 1MG 20 FILM COATED TABLETS /11 DAR AL DAWA JORDANIE RAZVAN 100ML ORAL SOLUTION /11 DAR AL DAWA JORDANIE Page 9
10 REBACIP 10 10MG 15 ENTERIC COATED TABLETS /09 CIPLA LTD INDE REBACIP 20 20MG 15 ENTERIC COATED TABLETS /09 CIPLA LTD INDE RECOMBINATE 250IU POWDER AND SOLVENT FOR SOLUTION FOR INJECTION /10 * BAXTER S.A FOR BAXTER AG- SWITZERLAND BELGIQUE RECOMBINATE 500IU POWDER AND SOLVENT FOR SOLUTION FOR INJECTION /10 * BAXTER S.A FOR BAXTER AG- SWITZERLAND BELGIQUE RECOMBINATE 1000IU POWDER AND SOLVENT FOR SOLUTION FOR INJECTION /10 * BAXTER S.A FOR BAXTER AG- SWITZERLAND BELGIQUE REMEPRAZOLE 20 20MG 14 CAPSULES 24656/07 REMEDICA LTD CHYPRE ROSUCOR 10MG 30 FILM COATED TABLETS /11 PHARMALINE Page 10
11 ROSUCOR 20MG 30 FILM COATED TABLETS /11 PHARMALINE ROSUCOR 40MG 30 FILM COATED TABLETS /11 PHARMALINE SILOSIN 4MG 30 CAPSULES /11 SILOSIN 8MG 30 CAPSULES /11 ALGORITHM S.A.L UNDER LICENSE FROM RECORDATI IRELAND LTD AND KISSEI PHARMACEUTICAL CO. LTD- JAPAN ALGORITHM S.A.L UNDER LICENSE FROM RECORDATI IRELAND LTD AND KISSEI PHARMACEUTICAL CO. LTD- JAPAN SODIUM BICARBONATE 8.4% 8.40% 50 ML X 20 VIALS SOLUTION FOR I.V USE ید فع الصندوق بالابرة 24549/07 PHARMACEUTICAL SOLUTIONS INDUSTRY LTD ARABIE SEOUDITE SPASMEX 30MG 50 FILM COATED TABLETS /09 DR. R.PFLEGER CHEMISCHE FABRIK GMBH FOR FERRING GMBH-GERMANY ALLEMAGNE Page 11
12 STALEVO 75MG+18.75MG +200MG 100 FILM COATED TABLETS /10 ORION CORPORATION FOR NOVARTIS PHARMA A.G.- SWITZERLAND FINLANDE STALEVO 125MG MG 100 FILM COATED TABLETS /10 ORION CORPORATION FOR NOVARTIS PHARMA A.G.- SWITZERLAND FINLANDE STERILE VANCOMYCIN HYDROCHLORIDE USP 500MG 10 VIALS POWDER FOR I.V. USE /10 HOSPIRA INC USA STERILE VANCOMYCIN HYDROCHLORIDE USP 1G 10 VIALS POWDER FOR I.V. USE /10 HOSPIRA INC USA TERAFAN 10MG/ML 15ML TOPICAL SPRAY /10 MEDIPHAR LABORATORIES TWYNSTA 80/5MG 28 TABLETS /11 BOEHRINGER INGELHEIM PHARMA GMBH&CO KG FOR BOEHRINGER INGELHEIM INTERNATIONAL GMBH ALLEMAGNE Page 12
13 TWYNSTA 80/10MG 28 TABLETS /11 BOEHRINGER INGELHEIM PHARMA GMBH&CO KG FOR BOEHRINGER INGELHEIM INTERNATIONAL GMBH ALLEMAGNE VELCADE 1MG 1 VIAL POWDER FOR SOLUTION FOR INJECTION 96236/11 * BENVENUE LABORATORIES INC USA FOR JANSSEN PHARMACEUTICA N.V- BELGIUM USA VERTINEX 16MG 20 TABLETS /11 MEDIPHAR LABORATORIES VEXOL 1% 5ML EYE DROPS /10 ALCON-COUVREUR BELGIQUE VOLAR 400MG 30 CAPSULES /10 DAR AL DAWA JORDANIE VOXIN 500MG 1 VIAL OF POWDER FOR /10 VIANEX S.A.-PLANT C GRECE XELODA 500MG 120 TABLETS 96353/11 * PRODUCTOS ROCHE S.A DE CV FOR F.HOFFMANN LA ROCHE LTD-SWITZERLAND MEXIQUE Page 13
14 YUTOPAR 10MG 20 TABLETS /11 SAJA PHARMACEUTICALS ARABIE SEOUDITE ZELAX MG 30 CAPLETS /08 JOSWE MEDICAL( JORDAN SWEDEN MEDICAL AND STERILIZATION CO.) JORDANIE ZENTEL 400MG 1 TABLET 96443/11 * GLAXOSMITHKILNE SOUTH AFRICA(PTY) LTD FOR GLAXOSMITHLINE AG LIMITED- SWITZERALND AFRIQUE DU SUD Page 14
Legal Supplement Part B Vol. 57, No. 6 18th January, NOTIFICATION NOTICE OF APPROVAL IN RESPECT OF NEW DRUGS
Legal Supplement Part B Vol. 57, No. 6 18th January, 2018 11 LEGAL NOTICE NO. 5 REPUBLIC OF TRINIDAD AND TOBAGO FOOD AND DRUGS ACT, CHAP. 30:01 NOTIFICATION NOTICE OF APPROVAL IN RESPECT OF NEW DRUGS ISSUED
Quality of medicines in Portugal: a retrospective review of medicine recalls ( ) Ana Teresa Reis Bruna Berardo Rui Loureiro
Quality of medicines in Portugal: a retrospective review of medicine recalls (2005-2015) Ana Teresa Reis Bruna Berardo Rui Loureiro Introduction Human medicines Cosmetics Veterinary medicines Medical devices
Iraq NDI Iraq 04-J India 05-AH France Famar Lyon France 05-D UNITED ARAB EMIRATES. Iraqi Biocon Limited Indian 06-AA0-001
nam origmanufacturer nammanufacturer National code Mousel Scientific Iraq NDI Iraq 04-J00-042 Sandoz GmbH Austria for Sandoz GmbH by Sandoz Ilac Sanayi ve India 05-AH0-040 France Famar Lyon France 05-D00-024
GUIDELINE ON THE CATEGORISATION OF EXTENSION APPLICATIONS (EA) versus VARIATIONS APPLICATIONS (V) OCTOBER 2003
EUROPN COMMISSION ENTERPRISE DIRECTORATE-GENERAL Single market, implementation and legislation for consumer goods Pharmaceuticals : regulary framework and market authorisations Brussels, F2/AW D(2002)
Medicines availability short-term supply issues Last updated 01/05/18
Short-term supply issues This resource includes availability information on medicines that are reported to have supply issues, with next expected availability within the next three months. This list is
Systemic and inhaled fluoroquinolones: risk of aortic aneurysm and dissection
Direct Healthcare Professional Communication 23 rd October 2018 Systemic and inhaled fluoroquinolones: risk of aortic aneurysm and dissection Dear Healthcare Professional, The Marketing Authorisation Holders
List of nationally authorised medicinal products
11 February 2016 EMA/255959/2016 Procedure Management and Committees Support Active substance: calcitonin salmon, synthetic analogue of eel calcitonin Procedure No.: PSUSA/00000494/201506 30 Churchill
Marketing authorisations granted in September 2012
PL 00037/0648 03/09/2012 ABBOTT LABORATORIES LIMITED LEVELANZ 250 MG FILM-COATED TABLETS LEVETIRACETAM 250 MILLIGRAMMES POM PL 00037/0649 03/09/2012 ABBOTT LABORATORIES LIMITED LEVELANZ 500 MG FILM-COATED
Free Trial Future Generics Database
API Atazanavir Structure O 2 C N H O H N OH N NH O N H N CO2 Brand REYATAZ (BMS : World) Indication Antiviral Originator Ciba-Geigy (Novartis) Developer / Licensee BMS Comments Atazanavir is an azapeptide
MEDICINES FOR SMOKING CESSATION: GLOBAL MARKETS. PHM154A September Anand Gijare Project Analyst ISBN:
MEDICINES FOR SMOKING CESSATION: GLOBAL MARKETS PHM154A September 2013 Anand Gijare Project Analyst ISBN: 1-56965-544-8 BCC Research 49 Walnut Park, Building 2 Wellesley, MA 02481 866-285-7215, 781-489-7301
by author The geographic disbalance in scientific publications ECCMID 2012, London Prof. Didier Raoult, Marseille, France CMI Editor-in-chief
The geographic disbalance in scientific publications ECCMID 2012, London Prof. Didier Raoult, Marseille, France CMI Editor-in-chief NUMBERS Lab Times. 1-2011. Ranking. Publication Analysis 1997-2008. Microbiology;
(Invented) Name Strength Pharmaceutical form. Ergotop 10 mg - Tabletten. Ergotop 20 mg - Filmtabletten. Ergotop 30 mg - Filmtabletten
Annex I List of the names, pharmaceutical (s), strength(s) of the medicinal product(s), route(s) of, marketing authorisation holder(s) in the member states 1 Bulgaria Bulgaria Czech Republic Kwizda Pharma
Price Changes advised by Pharmac As at 12 June 2015
s advised by Pharmac New to be available ex Manufacturer from 12th of preceding month. From Wholesale from date of supplier support which could vary. Product Supplier Schedule % + or - 01 Jun 15 31 Oct
List of nationally authorised medicinal products
5 November 2015 EMA/230130/2016 Procedure Management and Committees Support Active substance: cabergoline Procedure no.: PSUSA/00000477/201503 30 Churchill Place Canary Wharf London E14 5EU United Kingdom
med Origin of the product Generic name Lenalidomi de 10mg tablet or cap
Company name Company origin Manufacturer name Manufacturer origin National code Generic name Origin of the product Units per pack Units per blister"if applicable " Price per pack Price per unit Type of
WESTERN EUROPE PREVALENCE AND INCIDENCE OF PERIPHERAL ARTERY DISEASE AND CRITICAL LIMB ISCHEMIA 2017
WESTERN EUROPE PREVALENCE AND INCIDENCE OF PERIPHERAL ARTERY DISEASE AND CRITICAL LIMB ISCHEMIA 2017 Mary L. Yost 404-520-6652 , LLC 23 Ridge Rd. Beaufort, SC 20097 Copyright Pending 2017 All rights reserved,
Class I Drugs Event Event ID: Product Type: Status: Date Terminated: Recall Initiation Date: Voluntary / Mandated: Center Classification Date:
Class I Event 76678 12/29/2015 06/13/2017 E-Mail Complete Pharmacy and Medical Solutions LLC 5829 Nw 158th St Miami Lakes FL United States Distributed throughout Florida Human Chorionic Gonadotropin, 125
Table A1: Fifty Most Often Repeated Oral Drug Product Shortages (35 ingredients), Canada,
1 Appendix Commentary 515 Appendix: Assessing Canada s Drug Shortage Problem Table A1: Fifty Most Often Repeated Oral Drug Product Shortages (35 ingredients), Canada, 2013 16 Drug Name Dosage Therapeutic
Recommendation:- The 19 th SEC - (Oncology & Hematology) deliberated the proposals on and recommended the following:-
Recommendation:- The 19 th SEC - (Oncology & Hematology) deliberated the proposals on 05.11.2014 and recommended the following:- Agend a No. File No. 1. File No.: 12-75/13-DC Afatinib film coated tablet
Enforcement Report - Week of July 19, 2017
Enforcement Report - Week of July 19, 2017 Class I Event 77055 04/18/2017 Press Release Organic Herbal Supply 8303 Sierra College Blvd Ste 128 Roseville CA United States Nationwide via internet UPROAR
MEDICINES CONTROL COUNCIL
MEDICINES CONTROL COUNCIL NOTIFICATION OF REGISTRATION OF MEDICINES BY THE REGISTRAR IN TERMS OF SECTION 17 OF THE MEDICINES AND RELATED SUBSTANCES ACT, 1965 (ACT 101 OF 1965) 42/2.5/0453 ZYDUS HEALTHCARE
Injection Dosage Calculations
INJECTIONS: QUIZ 3 Injection Dosage Calculations 1. A child is ordered 9 mg of gentamicin by IM. Stock ampoules contain 20 mg in 2 ml. What volume is needed for the injection? a. 0.9 ml b. 0.5 ml c. 2.2
CHAPTER FOUR: UPDATE ON THE AIDS PANDEMIC TABLE 2 MILESTONES IN THE HISTORY OF HIV/AIDS TABLE 2 (CONTINUED) REGIONAL OVERVIEW...
CHAPTER ONE: INTRODUCTION... 1 STUDY GOALS AND OBJECTIVES... 1 REASONS FOR DOING THE STUDY... 1 SCOPE OF REPORT... 1 MARKET ANALYSES AND FORECASTS... 2 INTENDED AUDIENCE... 2 INFORMATION SOURCES... 2 ANALYST
TABLE OF CONTENTS 1 Table of Contents 2 Introduction 3 Key Marketed Products
TABLE OF CONTENTS 1 Table of Contents 1.1 List of Tables 1.2 List of Figures 2 Introduction 2.1 Epidemiology 2.2 Symptoms 2.3 Etiology 2.4 Pathophysiology 2.5 Co-morbidities and Complications 2.6 Classification
List of nationally authorised medicinal products
3 December 2015 EMA/98477/2016 Procedure Management and Committees Support Active substance: acarbose Procedure no.: PSUSA/00000017/201503 30 Churchill Place Canary Wharf London E14 5EU United Kingdom
Chemical compatibility of the Pall QPoint TM Docking Station - Tap Assembly with common surface disinfectants
Technical Report.78a Chemical compatibility of the Pall QPoint TM - Tap Assembly with common surface disinfectants QPoint - More than Filtration .0 Background The Pall QPoint Tap Water Filter Assembly
Kern Pharma Portfolio 2014
Kern Pharma Portfolio 2014 DOSSIERS DEVELOPED DURING 2013-2014 ARIPIPRAZOL (ODT) 10mg, 15mg tablets CHONDROITIN SULPHATE 400mg capsules ( well established use ) DEXKETOPROFEN TROMETAMOL 25mg, tablets DULOXETIN
Pharmaceutical Preparation For Internal Use
Pharmaceutical Preparation For Internal Use 1. Solid Preparations (Tablet, Capsule, Pill) 2. Liquid Preparations (Aqua, Syrup, Elixir, Extract, Liquor, Emulsion, Mixture, Infusion, Decoction). 3. Powder
(Invented) Name Strength Pharmaceutical form. Effortil comp. - Tropfen 2 mg/ml, 10 mg/ml. 2.5 mg prolonged-release capsule, hard
Annex I List of the names, pharmaceutical (s), strength(s) of the medicinal product(s), route(s) of, marketing authorisation holder(s) in the member states 1 Boehringer Ingelheim RCV GmbH & Co KG, Dr.
Country of Supplyin g Compan y. Supplyin g Compan y. Novartis Pharma Services Inc. Switzerla nd. Novartis Pharma Services Inc.
Generic Supplin Countr Supplin urin Oriin in c 1/2015 15-B00-029 Imatinib as meslate (Protein Trosine kinase inhibitor) 100m Capsule Glivec 100 Novartis Services Inc. Novartis AG 120 115% 2174.3 $ 1/2015
Please note that this draft Annex I will be updated to amend information on concerned products/mahs
22 March 2018 EMA/197481/2018 Annex I List of the names, pharmaceutical forms, strengths of the medicinal products, routes of, applicants, marketing authorisation holders in the member states for for omega-3
List of nationally authorised medicinal products
11 October 2017 EMA/784453/2017 Human Medicines Evaluation Division List of nationally authorised medicinal products Active substance(s): ipratropium / salbutamol Procedure No.: PSUSA/00001781/201701 30
Pediatric Medication Calculations
SECTION 7 Pediatric Medication Calculations CHAPTER 0 Pediatric Oral and Parenteral Medications CHAPTER Pediatric Intravenous Medications 00 Cengage Learning. All Rights Reserved. May not be scanned, copied
WellCare s South Carolina Preferred Drug List Update
WellCare s South Carolina Preferred Drug List Update This is a list of changes to our preferred drug list. These are a result of the latest WellCare Pharmacy & Therapeutics meeting held on 09/21/2017.
Pharmaceutical. Injection/Concentrate. 25ml Vial , ml Vial Injection/Solution for 2ml Ampoule x
1 ANZATAX 300mg/50ml (Multi Dose) m Injection/Concentrate 2 ANZATAX 150mg/25ml Infusion/Concentrate 3 ABRAXANE 100mg Injection/Suspension 4 ANZATAX 30mg/5ml Infusion/Concentrate 5 MEDACEF 500mg Capsules
New Exception Status Benefits
AUGUST 2017 Nova Scotia Formulary Updates New Exception Status Benefits Forxiga (dapagliflozin) Xigduo (dapagliflozin and metformin hydrochloride) Criteria Update: Antipsychotic Medications Abilify (aripiprazole)
REGULATORY UPDATES: APPROVAL, DENIALS AND AGREEMENTS REGULATORY UPDATES: APPROVAL, (CONTINUED)... 38
CHAPTER ONE: INTRODUCTION... 1 STUDY OBJECTIVES... 1 REASONS FOR DOING THIS STUDY... 1 INTENDED AUDIENCE... 2 SCOPE OF THE STUDY... 2 METHODOLOGY... 2 INFORMATION SOURCES... 2 ABOUT THE AUTHOR... 3 RELATED
DRAINAGE. Merit.com. Corporate Headquarters, South Jordan, Utah USA. Austria Norway
AGE Corporate Headquarters, South Jordan, Utah USA Merit Medical Systems, Inc. 1600 West Merit Parkway South Jordan, Utah 84095 1.801.253.1600 1.800.35.MERIT Merit Medical Europe, Middle East, & Africa
67 Years of Leadership in Pharmacy. A Journey of Continuous Improvement
67 Years of Leadership in Pharmacy A Journey of Continuous Improvement September 2012 GALENIKA A.D. IS The only Serbian state-owned pharmaceutical company Manufacturer of generic drugs its manufacturing
MEDICINES CONTROL COUNCIL
Notification of of Medicines MEDICINES CONTROL COUNCIL NOTIFICATION OF REGISTRATION OF MEDICINES BY THE REGISTRAR IN TERMS OF SECTION 17 OF THE MEDICINES AND RELATED SUBSTANCES ACT, 1965 (ACT 101 OF 1965)
MEDICINES CONTROL COUNCIL
MEDICINES CONTROL COUNCIL NOTIFICATION OF REGISTRATION OF MEDICINES BY THE REGISTRAR IN TERMS OF SECTION 17 OF THE MEDICINES AND RELATED SUBSTANCES ACT, 1965 (ACT 101 OF 1965) 41/20.1.1/0039 SCP MYLAN
Package leaflet: Information for the patient. Paracetamol 10 mg/ml solution for infusion. Paracetamol
Package leaflet: Information for the patient Paracetamol Read all of this leaflet carefully before you are given this medicine because it contains important information for you. - Keep this leaflet. You
THE CORPORATE REPUTATION OF PHARMA 2015 THE PERSPECTIVE OF 139 PATIENT GROUPS with an interest in DIABETES
THE CORPORATE REPUTATION OF PHARMA 2015 THE PERSPECTIVE OF 139 PATIENT GROUPS with an interest in DIABETES PUBLISHED AUGUST 2016 There is growing distrust of pharma in light of several recent and dramatic
List of nationally authorised medicinal products
01 December 2016 Human Medicines Evaluation Division Active substance: Procedure no.: PSUSA/00002591/201604 30 Churchill Place Canary Wharf London E14 5EU United Kingdom Telephone +44 (0)20 3660 6000 Facsimile
Prescription Drugs. Medicare & Medicaid Briefings National Health Policy Forum February 22, Jim Hahn Congressional Research Service
Prescription Drugs Medicare & Medicaid Briefings National Health Policy Forum February 22, 2007 Jim Hahn Congressional Research Service Global and US. Prescription Drug Sales, 1998-2005 $700 $600 559 602
INFORMATION TOPIC: II-5 OR DEMONSTRATION: II-5. DOSAGE, MEASUREMENTS, AND DRUG FORMS (Lesson Title) OBJECTIVES THE STUDENT WILL BE ABLE TO:
LESSON PLAN: 5 COURSE TITLE: UNIT: II MEDICATION TECHNICIAN GENERAL PRINCIPLES SCOPE OF UNIT: This unit includes medication terminology, dosage, measurements, drug forms, transcribing physician s orders,
Organ Transplantation Market Research Report- Global Forecast Till 2023
Report Information More information from: https://www.marketresearchfuture.com/reports/915 Organ Transplantation Market Research Report- Global Forecast Till 2023 Report / Search Code: MRFR/HC/0410-HCRR
Member State Marketing autorisation Holder Invented Name Strength Pharmaceutical form Route of administration
ANNEX I LIST OF THE NAMES, PHARMACEUTICAL FORM, STRENGTH OF THE MEDICINAL PRODUCTS, ROUTE OF ADMINISTRATION, MARKETING AUTHORISATION HOLDERS IN THE MEMBER STATES 1 Member State Marketing autorisation Holder
GOVERNMENT GAZETTE OF THE REPUBLIC OF NAMIBIA. N$2.00 WINDHOEK - 3 June 2011 No. 4726
GOVERNMENT GAZETTE OF THE REPUBLIC OF NAMIBIA N$2.00 WINDHOEK - 3 June 2011 No. 4726 CONTENTS Page GOVERNMENT NOTICE No. 71 Medicines and Related Substances Control Act, 2003: Registration of certain medicines...
(Invented) Name Strength Pharmaceutical Form. 3 mg/3 ml Solution for injection. Kytril 2 mg - Filmtabletten 2 mg Film-coated tablet Oral use
ANNEX I LIST OF THE NAMES, PHARMACEUTICAL FORMS, STRENGTHS OF THE MEDICINAL PRODUCTS, ROUTES OF ADMINISTRATION, MARKETING AUTHORISATION HOLDERS IN THE MEMBER STATES 1 Austria Austria Bulgaria Bulgaria
Global Aspergillosis Drugs Market Professional Survey Report 2016
Report Information More information from: https://www.wiseguyreports.com/reports/526011 Global Aspergillosis Drugs Market Professional Survey Report 2016 Report / Search Code: WGR526011 Publish Date: 24
EXHIBIT 21 SUBSIDIARIES
SUBSIDIARIES EXHIBIT 21 Johnson & Johnson, a corporation, had the U.S. and international subsidiaries shown below as of December 31, 2017. Certain U.S. subsidiaries and international subsidiaries are not
Advance Notification of Amendments to the December 2018 Drug Tariff
Advance Notification of Amendments to the December 2018 Drug Tariff ADDITIONS Zero Discount Fondaparinux sodium solution for injection pre-filled (ALL) FreeStyle Libre Sensor Oxygen CD cylinder Oxygen
Annex I. List of nationally authorised medicinal products and marketing authorisation applications
Annex I List of nationally authorised medicinal products and marketing authorisation applications 1 Annex IA: Medicinal products recommended for maintenance and marketing authorisation applications for
MEDICINES CONTROL COUNCIL
MEDICINES CONTROL COUNCIL NOTIFICATION OF REGISTRATION OF MEDICINES BY THE REGISTRAR IN TERMS OF SECTION 17 OF THE MEDICINES AND RELATED SUBSTANCES ACT, 1965 (ACT 101 OF 1965) 08/3.1.2/14 INGELHEIM A39/34/0605
MEDICINES CONTROL COUNCIL
Notification of of Medicines MEDICINES CONTROL COUNCIL NOTIFICATION OF REGISTRATION OF MEDICINES BY THE REGISTRAR IN TERMS OF SECTION 17 OF THE MEDICINES AND RELATED SUBSTANCES ACT, 1965 (ACT 101 OF 1965)
CONTRACT UPDATE June 15, 2012
CONTRACT UP June 15, 2012 ADDS HYDRALAZINE INJECTION 20MG/ML 1MLX25 17478-0934-15 $143.03 AKORN 06-15-2012 12-31-2013 178739 10106085 ADDS BENZONATATE CAPSULE 100MG 100 65162-0536-10 $9.95 AMNEAL PHARMACEUTICALS
Table updated 15 th February Sodium valporate 15 th February Ramipril & Felodipine 15 th February 2019
This table contains information on shortages of human medicines notified to the Health Products Regulatory Authority that have been resolved in the last 6 months. Table updated 15 th February 2019 Product
The health economic landscape of cancer in Europe
1 Approval number The health economic landscape of cancer in Europe Bengt Jönsson, Professor Emeritus of Health Economics Stockholm School of Economics 2 Disclaimer This presentation was developed by Professor
905 UNIFORMITY OF DOSAGE UNITS
Change to read: 905 UNIFORMITY OF DOSAGE UNITS [ NOTE In this chapter, unit and dosage unit are synonymous. ] To ensure the consistency of dosage units, each unit in a batch should have a drug substance
MEDICINES CONTROL COUNCIL
MEDICINES CONTROL COUNCIL NOTIFICATION OF REGISTRATION OF MEDICINES BY THE REGISTRAR IN TERMS OF SECTION 17 OF THE MEDICINES AND RELATED SUBSTANCES ACT, 1965 (ACT 101 OF 1965) 07/3.1.2.2/23 NOVARTIS SA
INFORMATION TOPIC: II-5 OR DEMONSTRATION: II-5. DOSAGE, MEASUREMENTS, AND DRUG FORMS (Lesson Title) OBJECTIVES THE STUDENT WILL BE ABLE TO:
LESSON PLAN: 5 COURSE TITLE: UNIT: II MEDICATION TECHNICIAN GENERAL PRINCIPLES SCOPE OF UNIT: This unit includes medication terminology, dosage, measurements, drug forms, transcribing physician s orders,
Status of Import License (Form 10) of Recombinant Products, Human and Veterinary Vaccines issued from 01/03/2016 to 29/04/2016
1. M/s LG Life Sciences India Pvt. Ltd.,Basement Commercial SCO No. 321, Sector-29, Gurgaon, India 2. M/s Eli Lilly and Co (I) Pvt. Ltd., Bldg. No. 14, Gala No. 1 to 4, 1 st Fl, Arihant Comm. Complex,
Global Trade in Lightweight Coated Writing Paper TradeData International Pty Ltd (www.tradedata.net) Page 1 5/18/2015
Page 1 5/18/2015 An Analysis of Global Trade in Lightweight paper, coated with inorganic substances, used for writing etc., of which more than 10% by weight of total fibre content consists of fibres obtained
Peritoneal Dialysis. Life Improved
Peritoneal Dialysis Life Improved Peritoneal Dialysis Flex-Neck ExxTended Upper Chest The Flex-Neck Adult catheter has an internal diameter of 3.5 mm, allowing up to 30% higher flow rates than other catheters
Kenneth Gordon, 1 Kim A. Papp, 2 Kara Creamer Rice, 3 Mona Trivedi, 3 David H. Collier, 3 Greg Kricorian 3
American Academy of Dermatology 75 th Annual Meeting, Orlando, FL; March 3 7, 2017 Poster 4563 Novel Evaluation of Psoriasis Area and Severity Index (PASI) Data: Distribution of PASI Improvements in a
Pharmaceutical, Medical and Health-related Government and Regulatory bodies around the world.
1 International International Conference on Harmonization (ICH) World Health Organization (WHO) 2 Argentina National Administration of Drugs, Food and medical Technology. Australia s Department of health
What was the study about?
Dear Reader, Pharmaceutical companies (sponsors) plan and conduct clinical studies to test medicines. Afterwards, they write study reports. A study report describes how a study was done and what the results
MEDICINES CONTROL COUNCIL
MEDICINES CONTROL COUNCIL NOTIFICATION OF REGISTRATION OF MEDICINES BY THE REGISTRAR IN TERMS OF SECTION 17 OF THE MEDICINES AND RELATED SUBSTANCES ACT, 1965 (ACT 101 OF 1965) A05/11.5/08 A38/20.1.1/0406
What Is. Is the combination of two or more things to produce something that neither component could produce alone.
What Is Is the combination of two or more things to produce something that neither component could produce alone. 1 Our Skills Synergy Swiss Pharma has an experienced team with collective knowledge and
EPAG Perspective - Regulatory Advances Related to Nasal Spray Pumps. Dr G.Williams Nasal Drug Delivery Management Forum London, 15 Apr 2010
1 EPAG Perspective - Regulatory Advances Related to Nasal Spray Pumps Dr G.Williams Nasal Drug Delivery Management Forum London, 15 Apr 2010 Overview 2 EPAG, what is it?, background, this project Regulatory
GLOBAL MARKETS FOR TREATMENT AND DIAGNOSIS OF SEXUALLY TRANSMITTED DISEASES
GLOBAL MARKETS FOR TREATMENT AND DIAGNOSIS OF SEXUALLY TRANSMITTED DISEASES PHM005C January 2013 Peggy Lehr Project Analyst ISBN: 0-89336-646-3 BCC Research 49 Walnut Park, Building 2 Wellesley, MA 02481
Influenza Vaccination Market Research Report Global Forecast till 2023
Report Information More information from: https://www.marketresearchfuture.com/reports/1621 Influenza Vaccination Market Research Report Global Forecast till 2023 Report / Search Code: MRFR/HC/1090-HCRR
PRACTICES OF COATING COLLECTION SURFACES OF CASCADE IMPACTORS: A SURVEY OF MEMBERS OF THE EUROPEAN PHARMACEUTICAL AEROSOL GROUP (EPAG)
PRACTICES OF COATING COLLECTION SURFACES OF CASCADE IMPACTORS: A SURVEY OF MEMBERS OF THE EUROPEAN PHARMACEUTICAL AEROSOL GROUP () J.P. Mitchell on behalf of members of the European Pharmaceutical Aerosol
DRAINAGE. MeritEMEA.com
DRAINAGE MeritEMEA.com Thoracentesis Biliary Drainage Nephrostomy Paracentesis Abscess Drainage COMPLETE DRAINAGE SOLUTIONS Merit Medical offers an integrated suite of products designed to support your
Palliative Coverage Drug Benefit Supplement
Palliative Coverage Drug Benefit Supplement Effective April 1, 2017 Inquiries should be directed to: Pharmacy Services Alberta Blue Cross 10009 108 Street NW Edmonton AB T5J 3C5 Telephone Number: (780)
Summary of Results for Laypersons
What was the Study Called? Summary of Results for Laypersons A Phase IIIb/IV Randomized, Controlled, Open-Label, Parallel Group Study to Compare the Efficacy of Vancomycin Therapy to Extended Duration
European Experience and Perspective on Assessing Value for Oncology Products. Michael Drummond Centre for Health Economics, University of York
European Experience and Perspective on Assessing Value for Oncology Products Michael Drummond Centre for Health Economics, University of York Outline of Presentation The European landscape on access to
PBS PRICE INCREASES - AUGUST 2014 SCHEDULE
Price increase review - general PBS benzylpenicillin 600 mg injection, 1 x 600 mg vial 1775K, 3398W, BenPen 3.84 4.38 3486L benzylpenicillin 3 g injection, 1 x 3 g vial 2647H, 3399X, BenPen 6.60 7.55 3487M
Allergan s Blephamide (sulfacetamide/prednisolone ophthalmic ointment) 10%/0.2%, 3.5Gm tube
Allergan s Blephamide (sulfacetamide/prednisolone ophthalmic ointment) 10%/0.2%, 3.5Gm tube On Aug. 24, 2015, Allergan recalled three lots (86258 expires September 2017, 87189 December 2017 and 87514 February
SAMPLE. South and Central America Drug Delivery Devices Market Outlook to Metered Dose Inhaler Devices, Infusion Systems, Central
South and Central America Drug Delivery Devices Market Outlook to 2018 - Metered Dose Inhaler Devices, Infusion Systems, Central Venous Catheters and Others Reference Code: GDME0222RDB Publication Date:
No. Description Packing UOM
Republic of the Philippines PITC Pharma, Inc. Bids and Awards Committee INVITATION TO BID VARIOUS GENERIC & ONCOLOGY MEDICINES, MEDICAL DEVICE & SUPPLIES (PROJECT REF. NO. BAC/GOODS 2016-02-002) The PITC
<1151> Pharmaceutical Dosage Forms and <1152> Animal Drugs for Use in Animal Feeds
Pharmaceutical Dosage Forms and Animal Drugs for Use in Animal Feeds Will Brown Veterinary Drugs Stakeholder Forum February 19-20, 2014 Development of a Compendial Taxonomy and Glossary for
EUROPEAN AEROSOL PRODUCTION
Introduction EUROPEAN AEROSOL PRODUCTION 2017 EU European production Market share Production by segment Worldwide production / FEA, 2018. 1 INTRODUCTION More than 5.7 billion over 16 billion units globally
NPPA has fixed/revised ceiling prices/retail prices of 22 formulations under Drugs (Prices Control) Order,
What s New 12.06.2018 NPPA has fixed/revised ceiling prices/retail prices of 22 formulations under Drugs (Prices Control) Order, 2013 NPPA has fixed/revised ceiling prices/retail prices of 22 formulations
Report ID: MRBT Publishing Date: July, 2017
Spirulina Market Outlook (2017-2022) Report ID: MRBT-10420 Publishing Date: July, 2017 Sr. No. License Type Price 1 Single User License $4,175.00 2 Multiple User Licence $6,575.00 3 Corporate User Licence
Access to treatment and disease burden
Access to treatment and disease burden Robert Flisiak Department of Infectious Diseases and Hepatology Medical University in Białystok, Poland Moulin de Vernègues, 27-29 August 2015 Disclosures Advisor
Supply should only occur if requesting signature is on approved list held by the issuing pharmacy
Trust Approved Drugs List March 2016 The following is the list of drugs that are approved by the EEAST Medicines Management Group for use by EEAST clinical staff. Pharmacies are advised that this is the
MEDICINES CONTROL COUNCIL
MEDICINES CONTROL COUNCIL NOTIFICATION OF REGISTRATION OF MEDICINES BY THE REGISTRAR IN TERMS OF SECTION 17 OF THE MEDICINES AND RELATED SUBSTANCES ACT, 1965 (ACT 101 OF 1965) 36/20.1.2/0204 BIOTECH 36/20.1.2/0205
CONTRACT UPDATE July 20, 2012
CONTRACT UP July 20, 2012 ADDS AMPHETAMINE SALT MIX ER CAPSULE 10MG 100 002-3059-11 $422.45 ACTAVIS ADDS AMPHETAMINE SALT MIX ER CAPSULE 20MG 100 002-3060-11 $422.45 ACTAVIS ADDS AMPHETAMINE SALT MIX ER
Advance Notification of Amendments to the August 2018 Drug Tariff
Advance Notification of Amendments to the August 2018 Drug Tariff ADDITIONS Zero Discount Brivaracetam 100mg tablets Brivaracetam 25mg tablets Brivaracetam 50mg tablets Brivaracetam 75mg tablets Maraviroc
PACKAGE LEAFLET: INFORMATION FOR THE USER ALBUNORM 20% 200 g/l, Solution for infusion Human albumin
PACKAGE LEAFLET: INFORMATION FOR THE USER ALBUNORM 20% 200 g/l, Solution for infusion Human albumin Read all of this leaflet carefully before you start using this medicine. Keep this leaflet. You may need
Table updated 26 th February Salbutamol 26 th February Lofepramine hydrochloride 22 nd February Zoledronic acid 21 st February 2019
This table contains information on shortages of human medicines notified to the Health Products Regulatory Authority that have been resolved in the last 6 months. Table updated 26 th February 2019 Product
Palliative Care Drug Benefit Supplement
Palliative Care Drug Benefit Supplement Effective April 1, 2007 Inquiries Inquiries should be directed to: Pharmacy Services Alberta Blue Cross 10009 108 Street NW Edmonton AB T5J 3C5 Telephone Number:
Package leaflet: Information for the patient. Hexvix 85 mg, powder and solvent for intravesical solution Hexaminolevulinate
Package leaflet: Information for the patient Hexvix 85 mg, powder and solvent for intravesical solution Hexaminolevulinate Read all of this leaflet carefully before you are given this medicine because
Thomas Karlsson & Esa Österberg National Research and Development Centre for Welfare and Health Alcohol and Drug Research Group P.O.
European Comparative Alcohol Study Europe and Alcohol Policy Thomas Karlsson & Esa Österberg National Research and Development Centre for Welfare and Health Alcohol and Drug Research Group P.O.BO 220 FIN-00531
Drug Dosage Calculations
8 Drug Dosage Calculations OUTLINE Overview Dosage and Doses The Desired Dose Calculating the Amount to Administer OBJECTIVES Upon completion of this chapter, the student should be able to: 1. Distinguish
MEDICINES CONTROL COUNCIL
MEDICINES CONTROL COUNCIL NOTIFICATION OF REGISTRATION OF MEDICINES BY THE REGISTRAR IN TERMS OF SECTION 17 OF THE MEDICINES AND RELATED SUBSTANCES ACT, 1965 (ACT 101 OF 1965) 47/26/0920 SANOFI-AVENTIS
Clinical Research Institute HUCH Sponsored, fully signed Clinical Trial Agreements (except grants)
, fully signed Clinical Trial Agreements (except grants) Sponsor Full name of the Hospital clinic where the is details of the January x x January x NightstaRx Ltd A Randomised, Open Label, Outcomes-Assessor
Barr Laboratories, Inc. et al.; Withdrawal of Approval of 68 Abbreviated New Drug Applications
This document is scheduled to be published in the Federal Register on 12/01/2017 and available online at https://federalregister.gov/d/2017-25920, and on FDsys.gov 4164-01-P DEPARTMENT OF HEALTH AND HUMAN